Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2013

Dec 4, 2013

30786_dirs_2013-12-04_1a977331-6e17-49a1-9069-45f53bdc5396.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2013-12-02

Reporting Person: SODERBERG SHAWN MARIE (EVP, General Counsel, Sec)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-12-02 Non-Qualified Stock Option (right to buy) $122.36 A 3250 Acquired 2023-12-02 Bio-Rad A Common Stock (3250) Direct
2013-12-02 Restricted Stock Units $0 A 1085 Acquired Bio-Rad A Common Stock (1085) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 0 Direct

Footnotes

F1: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.